Tatsis Ourania's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 22, 2023
- Accession no.
- 0001209191-23-011704
- Filed
- Feb 22, 2023
- Trade date
- Feb 17-21, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $141.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tatsis OuraniaCIK 0001789815 | Officer (EVP, Chief Reg. & Quality Off.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common Stock | FTax withholdingDisposed | −4,498 | $292.85 | −$1,317,239.3 | 60,947 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −4 | $291.01 | −$1,164.04 | 60,943 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −145 | $292.85F2,F3 | −$42,463.25 | 60,798 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −207 | $293.83F2,F4 | −$60,822.81 | 60,591 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −124 | $294.77F2,F5 | −$36,551.48 | 60,467 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $292.85 (range $292.37 to $293.36).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $293.83 (range $293.39 to $294.38).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $294.77 (range $294.42 to $295.37).
Referenced by the price of 1 transaction in Table I.